Get complete Patent Opposition Report for Allergan Pharmaceuticals

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Allergan Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP2800811Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of TranscriptionCHARPENTIERFeb 11, 2018

Explore Allergan Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3509559Jul 19, 2023Injectable Gels Comprising Cross-Linked Hyaluronic Acid And Hydroxyapatite, And Methods Of Manufacturing Thereof1
EP3024479Feb 8, 2023High Potency Pancreatin Pharmaceutical Compositions1
EP3003360Oct 7, 2020High Potency Pancreatin Pharmaceutical Compositions1
EP2922532Mar 6, 20195-Aminosalicylic Acid Capsule Formulation1
EP2818160Nov 8, 2017Enteric Coated, Low-Strength Pancrelipase Formulations1